AGPAT1 Rabbit Polyclonal Antibody (BF350)
AGPAT1 Rabbit Polyclonal Antibody (BF350) is a BF350 conjugated antibody targeting AGPAT1. This antibody is suitable for IF. It exhibits reactivity with Mouse, Rat samples.
Product Specifications
Product Name Alternative
1 AGPAT1; LPAAT alpha; LPAATA; MGC5423; 1 acyl sn glycerol 3 phosphate acyltransferase alpha; 1 acylglycerol 3 phosphate O acyltransferase 1 (acetoacetly Coenzyme A thiolase) ; 1 acylglycerol 3 phosphate O acyltransferase 1 (lysophosphatidic acid acyltransferase alpha) ; 1 acylglycerol 3 phosphate O acyltransferase 1; 1 AGP acyltransferase 1; AGPAT 1; G15 antibody Lysophosphatidic acid acyltransferase alpha; Lysophospholipid acyltransferase; MGC4007; OTTHUMP00000062693; Protein G15; Protein-G15. PLCA_HUMAN
Reactivity
Mouse, Rat
Immunogen
KLH conjugated synthetic peptide derived from human AGPAT1 (101-200/283aa)
Target
AGPAT1
Clonality
Polyclonal
Conjugation
BF350
Field of Research
Signal Transduction
Purification
Affinity purified by Protein A
Concentration
1mg/ml
Dilution
IF=1:100-500
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Prediction Reactivity
Bovine, Canine, Equine, Human, Porcine, Rabbit, Sheep
Tested Applications
IF
Host or Source
Rabbit
Preservative
0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MA10045-01 100 mg
3-Azidopropyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside
Sign In for Pricing
View Details MA10045-02 250 mg
3-Azidopropyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside
Sign In for Pricing
View Details MA10045-03 500 mg
3-Azidopropyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside
Sign In for Pricing
View Details MA10045-04 1000 mg
3-Azidopropyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside
Sign In for Pricing
View Details MA10045-05 2000 mg
3-Azidopropyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside
Sign In for Pricing
View Details 